Rchr
J-GLOBAL ID:201101047401746032   Update date: Oct. 03, 2024

Tagami Tatsuaki

タガミ タツアキ | Tagami Tatsuaki
Affiliation and department:
Job title: Associate Professor
Homepage URL  (2): https://nrd.nagoya-cu.ac.jp/profile/ja.4e37f85fac60821b.htmlhttps://nrd.nagoya-cu.ac.jp/profile/en.4e37f85fac60821b.html
Research field  (4): Pharmaceuticals - analytical and physicochemistry ,  Clinical pharmacy ,  Biomedical engineering ,  Composite materials and interfaces
Research keywords  (3): 3D printering of medicine ,  Pharmaceutical engineering ,  Nanomedicine
Research theme for competitive and other funds  (9):
  • 2023 - 2026 粘膜ワクチン応用に向けた粉末製剤化mRNA封入脂質ナノ粒子の開発
  • 2022 - 2026 Establishment of a method for reducing ischemia-reperfusion injury using ultrafine bubbles
  • 2023 - 2026 Pharmaceutical research using 3D printing technology to support the manufacture of medicine
  • 2020 - 2023 Novel platform for sustained release of biopharmaceucal by using porous PLGA particle
  • 2018 - 2022 Tumor specific siRNA delivery for KRAS mutant colorectal cancer
Show all
Papers (80):
  • Mingyue Gao, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki. Preparation and in vitro characterization of clofazimine-loaded albumin nanocomposite microparticles for inhalation therapy. Journal of Drug Delivery Science and Technology. 2024. 93. 105364-105364
  • Jin Liu, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki. Development of Hollow Gold Nanoparticles for Photothermal Therapy and Their Cytotoxic Effect on a Glioma Cell Line When Combined with Copper Diethyldithiocarbamate. Biological and Pharmaceutical Bulletin. 2024. 47. 1. 272-278
  • Hamid Alghurabi, Huda Jassim Muhammad, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki. Optimization, cellular uptake, and in vivo evaluation of Eudragit S100-coated bile salt-containing liposomes for oral colonic delivery of 5-aminosalicylic acid. International Journal of Pharmaceutics. 2023. 648. 123597-123597
  • Eiichi Goto, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki. Fabrication of 3D-Printed Contact Lens Composed of Polyethylene Glycol Diacrylate for Controlled Release of Azithromycin. Biological and Pharmaceutical Bulletin. 2023. 46. 10. 1461-1467
  • Ayaka Hanaki, Koki Ogawa, Tatsuaki Tagami, Tetsuya Ozeki. Fabrication and Characterization of Antibody-Loaded Cationic Porous PLGA Microparticles for Sustained Antibody Release. The AAPS Journal. 2023. 25. 6
more...
MISC (9):
  • Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki. Booster of the development of personalized therapy: Manufacture of tailored medicine using 3D printing technology. Drug Delivery System. 2022. 37. 4. 294-302
  • Tatsuaki Tagami, Koki Ogawa, Toshiro Fukami, Tetsuya Ozeki. Research and technical commentary: Recent studies about pharmaceutical cocrystals prepared by spray drying method. Journal of Japan Society of Pharmaceutical Machinery and Engineering. 2022. 31. 3. 14-20
  • Tatsuaki Tagami, Tetsuya Ozeki. Research and technology development: Recent research on preparation of dosage forms other than tablets using a 3D printer-gummy candies, chewable tablets, suppositories as an example- (Japanese). Journal of Japan Society of Pharmaceutical Machinery and Engineering. 2021. 30. 2. 19-25
  • Tatsuaki Tagami, Tetsuya Ozeki. Frontier research series: Manufacturing of medicines using 3D printers and application to tailor-made medicines tailored to patients (Japanese). Journal of the Society of Powder Technology, Japan. 2020. 57. 633-639
  • Tatsuaki Tagami, Tetsuya Ozeki. Recent topics related to research on 3D printers and tablets-From the standpoint of academia- (Japanese). PHARM TECH JAPAN. 2020. 36. 5. 145-152
more...
Books (2):
  • (Textbook) Latest pharmaceutics 11th edition
    Hirokawa-Shoten Ltd. 2018
  • (Textbook) Pharmaceutical science 7th edition
    Nankodo Co., Ltd 2017
Lectures and oral presentations  (4):
  • Drug development and formulation design using 3D printing technology
    (2023)
  • New model of medicine generated by business ecosystem with 3D printing technology
    (2023)
  • Unraveling the topics of recent pharmaceutical formulations in the point of pharmaceutical science
    (2022)
  • New formulations and pharmaceuticals brought about by 3D printer technology
    (2021)
Education (2):
  • 2007 - 2009 The University of Tokushima Graduate School of Pharmaceutical Sciences Doctral Course
  • 2001 - 2005 The University of Tokushima Faculty of Pharmaceutical Sciences School of Pharmacy
Professional career (1):
  • The PhD in Pharmaceutical Sciences (The University of Tokushima)
Work history (1):
  • 2021/05 - 現在 Nagoya City University Graduate School of Pharmaceutical Sciences Department of Drug Delivery and Nano Pharmaceutics Associate Professor
Committee career (2):
  • 2022/05 - 現在 Pharmaceutics Editorial Board Member, Pharmaceutical Technology, Manufacturing and Devices Section (Special Issue: 3D Printing Technology for Pharmaceutical and Biomedical Application)
  • 2018/01 - 現在 Chubu-area Colloquium, The Society of Powder Technology, Japan Executive Committee Member
Awards (2):
  • 2022/01 - The Pharmaceutical Society of Japan 2021 Highly Cited Article Award for BPB Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol Pharm Bull. (2017) 40(3):357-364.
  • 2020/02 - NAGAI Foundation for Science and Technology NAGAI Foundation Technology Award Novel drug formulation required for 3D printer-based manufacturing of medicine;
Association Membership(s) (6):
FORUM FOR PHARMACEUTICAL TECHNOLOGY INNOVATION ,  THE SOCIETY OF POWDER TECHNOLOGY, JAPAN ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN ,  THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page